ACHC Healthcare

Acadia Healthcare Company, Inc.

$29.62+0.00%

Price as of close on Nov 3, 2026 · Financials updated Oct 6, 2026

Basics

Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Market cap: 2.8B USD
Enterprise value: 5.0B USD
Full-time employees: 25,000

Overall health

Drawback: less profitable than most peersless profitable than peers
Drawback: growing more slowly than most peersgrowing more slowly than peers
Drawback: higher risk than most peers: less short-term liquidity (current ratio 1.57 vs a peer median of 2.59) and more debt relative to equity (1.22× vs a peer median of 0.22×)higher risk: less liquidity (current ratio 1.57 vs peers 2.59) and more debt vs equity (1.22× vs peers 0.22×)
About average: valuation

Ranks #932 of 1,157 healthcare companies (bottom 20%)

See how it ranks against its peers

Worth knowing

Earnings slid into a loss. Loss per share this year after a profit last year.
Acadia Healthcare made a loss per share in its latest year after a profit the year before.
Investment surge. Capital spending 17% of revenue, up from 11% in 2022.
Acadia Healthcare is spending 17% of revenue on facilities and equipment, up from 11% in 2022. That weighs on free cash flow today; whether it pays off depends on the returns those investments earn.
Valuation signals disagree. Cheaper than 82% of peers on operating cash profit (EBITDA), but only 0% on earnings.Cheaper than 82% of peers on operating cash profit, but only 0% on earnings.
Relative to its operating cash profit (EBITDA), Acadia Healthcare looks cheaper than 82% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.Relative to its operating cash profit, Acadia Healthcare looks cheaper than 82% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.
Loss over 12 months, profit last quarter. Lost money in the 12 months to June 2026, but made a $11M profit in the quarter to June 2026.
Acadia Healthcare reported a net loss over the last twelve months, but its most recent quarter was profitable ($11M). One quarter isn't a trend, but it's closer to profitability than the 12-month figure suggests.

StockQuotient Score

33/ 100

Oct 5 34 → Nov 4 33 (-1)

Valuation

Is the price right?

57/100

Moderate

3/3 inputs reported · High confidence

Since last quarter: No major changeValuation also moves with the share price every day.

Why

Mixed versus peers:

▲ EBITDA yield
▼ Earnings yield

Compare with peers

Behind the score

Sector-normalized EBITDA, earnings, and free cash flow yields.

Earnings yield-40.8%

SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.00Sector median: 0.0148 · MAD: 0.0148

EBITDA yield9.9%

Yahoo Finance fallback · SEC enterprise value unavailable (debt or EBITDA not reported in standard form) · trailing 12 monthsReported value50% base weight · Z-score 1.48Sector median: 0.0401 · MAD: 0.0401

Free cash flow yield-4.9%

SEC filings · 12 months to Jun 2026 · operating cash flow − capital spendingNegative (a loss or cash outflow), so it counts as zero whatever the share price20% base weight · Z-score 0.00Sector median: 0.0000 · MAD: 0.0000

Other data (not scored)

Book yield71.8%

SEC filings · latest balance sheetReported valueInformational · 0% composite weightSector median: 0.3716 · MAD: 0.2313

Growth

Is it growing?

28/100

Weak

3/3 inputs reported · High confidence

Since last quarter: No major change

Why

Weaker than most peers on:

▼ EPS growth

Compare with peers

Behind the score

Revenue and earnings-per-share growth over one year, and revenue growth over three years.

Earnings per share growthUnavailable

Earnings per share turned from a profit to a loss33% base weight · Z-score -1.99Sector median: 0.0976 · MAD: 0.2991

3-year revenue growth6.6%

SEC filings · 3 years to Jun 2026Reported value33% base weight · Z-score 0.09Sector median: 0.0584 · MAD: 0.0840

Revenue growth4.3%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score -0.19Sector median: 0.0609 · MAD: 0.0974

Profitability

Does it earn well?

30/100

Weak

3/3 inputs reported · High confidence

Since last quarter: No major change

Why

Weaker than most peers on:

▼ ROA

Compare with peers

Behind the score

Return on invested capital, operating margin, and return on assets.

Operating margin11.7%

Yahoo Finance fallback · SEC operating income not reported in standard form · fiscal year to Dec 2025Reported value33% base weight · Z-score 0.38Sector median: 0.0706 · MAD: 0.1217

Return on assets-20.3%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score -4.09Sector median: 0.0166 · MAD: 0.0537

Return on invested capital6.1%

Yahoo Finance fallback · SEC operating income or invested capital unavailable · trailing 12 monthsReported value33% base weight · Z-score 0.14Sector median: 0.0471 · MAD: 0.1004

Other data (not scored)

Gross margin41.1%

Yahoo Finance fallback · SEC figure unavailable or out of date · trailing 12 monthsReported valueInformational · 0% composite weightSector median: 0.4697 · MAD: 0.2310

Return on equity-56.9%

SEC filings · 12 months to Jun 2026Reported valueInformational · 0% composite weightSector median: 0.0330 · MAD: 0.1225

Risk

Debt, liquidity, price swings

Higher

Higher relative risk

3/3 inputs reported · High confidence

Since last quarter: No major change

Why

Weaker than most peers on:

▼ Debt / equity
▼ Current ratio

Compare with peers

Behind the score

Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.

Beta0.63

Yahoo Finance · 5-year monthly beta vs the marketReported value33% base weight · Z-score 0.00Sector median: 0.6250 · MAD: 0.3380

Current ratio1.57×

SEC filings · latest balance sheetReported value33% base weight · Z-score -0.73Sector median: 2.5860 · MAD: 1.3850

Debt / equity1.22×

SEC filings · latest balance sheetReported value33% base weight · Z-score -4.90Sector median: 0.2215 · MAD: 0.2039

Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.

Questions investors ask about Acadia Healthcare

Is Acadia Healthcare getting weaker?: Its latest SEC filing (Jul 28, 2026) showed no major changes. Its overall score is unchanged at 33/100 since Oct 28, 2026.
How is Acadia Healthcare valued vs its peers?: Priced about in line with its peers. Valuation scores 57/100 against 1,393 healthcare peers. EBITDA yield 9.9% vs a peer median of 4.0% (stronger than 82% of peers).EBITDA yield 9.9% vs peers 4.0% (stronger than 82% of peers). Earnings yield -40.8% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -40.8% vs peers 1.5% (weaker than 100% of peers).
Is Acadia Healthcare growing?: More slowly than most of its peers. Growth scores 28/100 against 1,393 healthcare peers.
How profitable is Acadia Healthcare?: Less profitable than most of its peers. Profitability scores 30/100 against 1,393 healthcare peers. Operating margin 11.7% vs a peer median of 7.1% (stronger than 63% of peers).Operating margin 11.7% vs peers 7.1% (stronger than 63% of peers). Return on assets -20.3% vs a peer median of 1.7% (weaker than 81% of peers).Return on assets -20.3% vs peers 1.7% (weaker than 81% of peers).
How risky is Acadia Healthcare?: Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Debt / equity 1.22× vs a peer median of 0.22× (weaker than 85% of peers).Debt / equity 1.22× vs peers 0.22× (weaker than 85% of peers). A relative measure, not a bankruptcy probability.

Latest filing: what changed

Quarter ended Jun 30, 2026 · filed Jul 28, 2026 · compared with the quarter ended Mar 31, 2026

No major changes

	Previous quarter	Latest quarter	Change
Revenue (12 months)	3.4B USD	3.4B USD	−0.1%
Net income (12 months)	−1.1B USD	−1.1B USD	+1.7%
Free cash flow (12 months)	−291.8M USD	−134.0M USD	−54.1%
Debt	2.5B USD	2.4B USD	−4.4%
Cash	158.5M USD	171.3M USD	+8.1%

From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.

Industry valuation context

Industry: Medical Care Facilities · 27 companies

Valuations in Medical Care Facilities are within their usual range since Jun 2017.

39% of months since Jun 2017 were valued lower than now.
28% of companies are in the most expensive fifth of their own price-to-sales history.
Median price-to-sales is −61% vs the whole market, against a usual −56%.

Jun 2017Shaded: most expensive fifth of its range2026

Financials

Fiscal years from SEC annual filings · change vs the prior year

Key ratios	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Change
Net margin	8.2%	10.5%	-0.7%	8.1%	-33.3%	▼ 41 pts
Return on assets (ROA)	4.0%	5.5%	-0.4%	4.3%	-20.0%	▼ 24 pts
Return on equity (ROE)	7.6%	9.7%	-0.8%	8.3%	-56.6%	▼ 65 pts
Free cash flow margin	5.6%	3.2%	1.3%	-17.8%	-13.3%	▲ 4.5 pts
Current ratio	1.22×	1.30×	0.67×	1.00×	1.55×	▲ 55%
Quick ratio	1.21×	1.29×	0.67×	0.99×	1.54×	▲ 56%
Debt to equity	0.59×	0.49×	0.49×	0.64×	1.28×	▲ 101%

ACHC price history

Price history is added with the daily price update and will appear after the next one.

Similar companies

Sector leaderboards

BB Biotech AGBBZA.DE100/ 100

Arbutus Biopharma CorporationABUS97/ 100

Q32 Bio Inc.QTTB97/ 100

Bringing the fundamentals into focus…

Overall health

Drawback: less profitable than most peersless profitable than peers

Drawback: growing more slowly than most peersgrowing more slowly than peers

Drawback: higher risk than most peers: less short-term liquidity (current ratio 1.57 vs a peer median of 2.59) and more debt relative to equity (1.22× vs a peer median of 0.22×)higher risk: less liquidity (current ratio 1.57 vs peers 2.59) and more debt vs equity (1.22× vs peers 0.22×)

About average: valuation

Ranks #932 of 1,157 healthcare companies (bottom 20%)

See how it ranks against its peers

Worth knowing

Earnings slid into a loss. Loss per share this year after a profit last year.

Acadia Healthcare made a loss per share in its latest year after a profit the year before.

Investment surge. Capital spending 17% of revenue, up from 11% in 2022.

Acadia Healthcare is spending 17% of revenue on facilities and equipment, up from 11% in 2022. That weighs on free cash flow today; whether it pays off depends on the returns those investments earn.

Valuation signals disagree. Cheaper than 82% of peers on operating cash profit (EBITDA), but only 0% on earnings.Cheaper than 82% of peers on operating cash profit, but only 0% on earnings.

Relative to its operating cash profit (EBITDA), Acadia Healthcare looks cheaper than 82% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.Relative to its operating cash profit, Acadia Healthcare looks cheaper than 82% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.

Loss over 12 months, profit last quarter. Lost money in the 12 months to June 2026, but made a $11M profit in the quarter to June 2026.

Acadia Healthcare reported a net loss over the last twelve months, but its most recent quarter was profitable ($11M). One quarter isn't a trend, but it's closer to profitability than the 12-month figure suggests.

Questions investors ask about Acadia Healthcare

Is Acadia Healthcare getting weaker?

Its latest SEC filing (Jul 28, 2026) showed no major changes. Its overall score is unchanged at 33/100 since Oct 28, 2026.

How is Acadia Healthcare valued vs its peers?

Priced about in line with its peers. Valuation scores 57/100 against 1,393 healthcare peers. EBITDA yield 9.9% vs a peer median of 4.0% (stronger than 82% of peers).EBITDA yield 9.9% vs peers 4.0% (stronger than 82% of peers). Earnings yield -40.8% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -40.8% vs peers 1.5% (weaker than 100% of peers).

Is Acadia Healthcare growing?

More slowly than most of its peers. Growth scores 28/100 against 1,393 healthcare peers.

How profitable is Acadia Healthcare?

Less profitable than most of its peers. Profitability scores 30/100 against 1,393 healthcare peers. Operating margin 11.7% vs a peer median of 7.1% (stronger than 63% of peers).Operating margin 11.7% vs peers 7.1% (stronger than 63% of peers). Return on assets -20.3% vs a peer median of 1.7% (weaker than 81% of peers).Return on assets -20.3% vs peers 1.7% (weaker than 81% of peers).

How risky is Acadia Healthcare?

Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Debt / equity 1.22× vs a peer median of 0.22× (weaker than 85% of peers).Debt / equity 1.22× vs peers 0.22× (weaker than 85% of peers). A relative measure, not a bankruptcy probability.

Previous quarter

Latest quarter

Change

Revenue (12 months)

3.4B USD

3.4B USD

−0.1%

Net income (12 months)

−1.1B USD

−1.1B USD

+1.7%

Free cash flow (12 months)

−291.8M USD

−134.0M USD

−54.1%

Debt

2.5B USD

2.4B USD

−4.4%

Cash

158.5M USD

171.3M USD

+8.1%

Key ratios

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Change

Net margin

8.2%

10.5%

-0.7%

8.1%

-33.3%

▼ 41 pts

Return on assets (ROA)

4.0%

5.5%

-0.4%

4.3%

-20.0%

▼ 24 pts

Return on equity (ROE)

7.6%

9.7%

-0.8%

8.3%

-56.6%

▼ 65 pts

Free cash flow margin

5.6%

3.2%

1.3%

-17.8%

-13.3%

▲ 4.5 pts

Current ratio

1.22×

1.30×

0.67×

1.00×

1.55×

▲ 55%

Quick ratio

1.21×

1.29×

0.67×

0.99×

1.54×

▲ 56%

Debt to equity

0.59×

0.49×

0.64×

1.28×

▲ 101%